These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2365199)

  • 1. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.
    Hayashi H; Higuchi T; Ichimiya H; Hishida N; Sakamoto N
    Gastroenterology; 1990 Aug; 99(2):533-5. PubMed ID: 2365199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of asymptomatic primary sclerosing cholangitis treated by ursodeoxycholic acid].
    Hayashi H; Higuchi T; Ichimiya H; Hishida N; Sakamoto N; Mitake M; Nakazawa S; Okuyama S
    Nihon Naika Gakkai Zasshi; 1989 Jan; 78(1):89-90. PubMed ID: 2732582
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.
    Beuers U; Spengler U; Zwiebel FM; Pauletzki J; Fischer S; Paumgartner G
    Hepatology; 1992 Apr; 15(4):603-8. PubMed ID: 1551637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.
    Beuers U; Spengler U; Kruis W; Aydemir U; Wiebecke B; Heldwein W; Weinzierl M; Pape GR; Sauerbruch T; Paumgartner G
    Hepatology; 1992 Sep; 16(3):707-14. PubMed ID: 1505913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of primary sclerosing cholangitis with ursodeoxycholic acid].
    Stiehl A; Raedsch R
    Z Gastroenterol Verh; 1989 Jul; 24():136. PubMed ID: 2474928
    [No Abstract]   [Full Text] [Related]  

  • 6. Ursodeoxycholic acid for primary sclerosing cholangitis.
    Chazouillères O; Poupon R; Capron JP; Metman EH; Dhumeaux D; Amouretti M; Couzigou P; Labayle D; Trinchet JC
    J Hepatol; 1990 Jul; 11(1):120-3. PubMed ID: 1975818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Wagner M; Marschall HU; Fuchsbichler A; Zollner G; Tsybrovskyy O; Zatloukal K; Liu J; Waalkes MP; Cover C; Denk H; Hofmann AF; Jaeschke H; Trauner M
    Gastroenterology; 2006 Feb; 130(2):465-81. PubMed ID: 16472600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis.
    Rudolph G; Endele R; Senn M; Stiehl A
    Hepatology; 1993 Jun; 17(6):1028-32. PubMed ID: 8514251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
    Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
    Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.
    Fracchia M; Soubrane O; Houssin D; Galatola G
    Ital J Gastroenterol; 1995; 27(8):430-5. PubMed ID: 8775469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases].
    Raedsch R; Stiehl A
    Klin Wochenschr; 1989 Feb; 67(4):265-8. PubMed ID: 2648062
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.
    Stiehl A; Walker S; Stiehl L; Rudolph G; Hofmann WJ; Theilmann L
    J Hepatol; 1994 Jan; 20(1):57-64. PubMed ID: 8201224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids.
    Higuchi T; Hishida N; Isomura T; Takeshima H; Hayashi H
    Gastroenterol Jpn; 1992 Apr; 27(2):222-9. PubMed ID: 1577228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid.
    Lee YM; Kaplan MM
    Curr Gastroenterol Rep; 1999; 1(1):38-41. PubMed ID: 10980925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of different doses of ursodeoxycholic acid in chronic liver disease.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):59S-65S. PubMed ID: 2598769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids for primary sclerosing cholangitis.
    Chen W; Gluud C
    Cochrane Database Syst Rev; 2003; (2):CD003626. PubMed ID: 12804480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry.
    Ewerth S; Angelin B; Einarsson K; Nilsell K; Björkhem I
    Gastroenterology; 1985 Jan; 88(1 Pt 1):126-33. PubMed ID: 3880555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.